Literature DB >> 3122245

Discriminative stimulus properties of muscarinic agonists.

M Jung1, L Costa, G T Shearman, P H Kelly.   

Abstract

In a two-lever, food-reinforced drug-discrimination paradigm separate groups of rats were trained to discriminate either arecoline, pilocarpine or oxotremorine from saline. The discriminative cues of all three agonists were potently blocked by scopolamine, but only by 30-60 fold higher doses of methylscopolamine. The three agonists all suppressed overall response rate. These rate-suppressant effects were not blocked by scopolamine in doses which blocked the discriminative cues. In generalization tests, arecoline elicited selection of the drug-appropriate lever in all groups of trained animals. Pilocarpine was discriminated as drug by all pilocarpine-trained animals and by a majority of oxotremorine-trained animals, but was not significantly discriminated by the arecoline-trained group. Oxotremorine was discriminated by all oxotremorine-trained animals but only by some pilocarpine-trained animals, and was not significantly discriminated by the arecoline-trained group. Morphine, haloperidol, chlordiazepoxide, pentobarbital and nicotine were not generalized to any of the training drugs. The discriminative stimuli produced by the training drugs are therefore specific and exhibit properties indicative of an origin at central muscarinic receptors but may not be identical.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3122245     DOI: 10.1007/bf00179923

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  18 in total

1.  The narcotic cue: evidence for the specificity of the stimulus properties of narcotic drugs.

Authors:  F C Colpaert; C J Niemegeers; P A Janssen
Journal:  Arch Int Pharmacodyn Ther       Date:  1975-12

2.  Behavioural and pharmacological characterization of the mouth movements induced by muscarinic agonists in the rat.

Authors:  J D Salamone; M D Lalies; S L Channell; S D Iversen
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

Review 3.  Experimental methods for the study of state-dependent learning.

Authors:  D A Overton
Journal:  Fed Proc       Date:  1974-07

4.  A description of the nicotine stimulus and tests of its generalization to amphetamine.

Authors:  W T Chance; D Murfin; G M Krynock; J A Rosecrans
Journal:  Psychopharmacology (Berl)       Date:  1977-11-24       Impact factor: 4.530

5.  Atropine antagonism of arecoline-cued behavior in the rat.

Authors:  M D Schechter; J A Rosecrans
Journal:  Life Sci I       Date:  1972-06-01

6.  Role of training dose in discrimination of nicotine and related compounds by rats.

Authors:  I P Stolerman; H S Garcha; J A Pratt; R Kumar
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

7.  Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue.

Authors:  E K Perry; P H Gibson; G Blessed; R H Perry; B E Tomlinson
Journal:  J Neurol Sci       Date:  1977-11       Impact factor: 3.181

Review 8.  Measurement of cholinergic drug effects on memory in Alzheimer's disease.

Authors:  S D Brinkman; S Gershon
Journal:  Neurobiol Aging       Date:  1983       Impact factor: 4.673

9.  Discriminative stimulus properties of arecoline: a new approach for studying central muscarinic receptors.

Authors:  L T Meltzer; J A Rosecrans
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

10.  Central muscarinic receptors and male rat sexual behavior: facilitation by oxotremorine but not arecoline or pilocarpine in methscopolamine pretreated animals.

Authors:  S Ahlenius; K Larsson
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

View more
  6 in total

Review 1.  Neuropharmacology of the interoceptive stimulus properties of nicotine.

Authors:  Thomas E Wooters; Rick A Bevins; Michael T Bardo
Journal:  Curr Drug Abuse Rev       Date:  2009-09

2.  Trends in drug discrimination research analysed with a cross-indexed bibliography, 1984-1987.

Authors:  I P Stolerman; F Rasul; P J Shine
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

3.  Pharmacological characterization of the physostigmine stimulus in rats.

Authors:  M Jung; A Perio; P Worms; P Soubrie
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

4.  Mianserin as a discriminative stimulus in rats: asymmetrical cross-generalization with scopolamine.

Authors:  B M Kelley; J H Porter; S A Varvel
Journal:  Psychopharmacology (Berl)       Date:  1995-08       Impact factor: 4.530

5.  Comparison of the muscarinic antagonist effects of scopolamine and L-687,306.

Authors:  Gail Winger; Emily M Jutkiewicz; James H Woods
Journal:  Behav Pharmacol       Date:  2020-06       Impact factor: 2.277

6.  Novel Antimuscarinic Antidepressant-like Compounds with Reduced Effects on Cognition.

Authors:  Chad R Johnson; Brian D Kangas; Emily M Jutkiewicz; Gail Winger; Jack Bergman; Andrew Coop; James H Woods
Journal:  J Pharmacol Exp Ther       Date:  2021-03-12       Impact factor: 4.402

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.